Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

J Arrhythm · 2018 · PMC5891422 · PMID 29657592

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

a strong trendP = .050actually significant

There was a strong trend for a lower rate of stroke/SE with rivaroxaban than warfarin (HR, 0.49; 95% CI, 0.24‐1.00; P = .050).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.